Jana De Brandt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jana De Brandt has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
- Andre Nyberg
Department of Community Medicine and Rehabilitation, Umeå University, Umeå, Sweden
6 shared publications Chris Burtin
Faculty of Rehabilitation Sciences, REVAL - Rehabilitation Research Center, BIOMED – Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium
4 shared publications- Chris Burtin
Hasselt University
4 shared publications - Martijn A. Spruit
Ciro
4 shared publications Wim Derave
Department of Movement and Sports Sciences, Ghent University, Ghent, Belgium
4 shared publications- Johan Jakobsson
Umea University, Department of Community Medicine and Rehabilitation, Umea, Sweden
3 shared publications
Latest Publications
- Open Access
- 1 April 2026
- Published by European Respiratory Society (ERS) in Breathe
- Vol. 22 (2) , 260026
Lung Facts: a practical tool to strengthen respiratory advocacy in Europe
Respiratory diseases remain a leading health burden across Europe, yet national strategies are often fragmented or absent. The International Respiratory Coalition's Lung Facts platform offers a comprehensive, up-to-date resource for epidemiological and economic data for major respiratory conditions across 53 European countries. This viewpoint outlines the platform's development and the types of data available, including disease burden, societal costs and risk factor attribution. It also demonstrates how national coalitions are using it to advocate for respiratory health policies. By providing accessible, country-specific information in visual formats, Lung Facts supports benchmarking, evidence-based advocacy and planning of national respiratory strategies. The platform is a dynamic tool intended to strengthen respiratory health policy and empower stakeholders to act on the growing burden of lung disease.
- 1 April 2026
- Published by European Respiratory Society (ERS) in Breathe
- Vol. 22 (2) , 260026
Open AccessLung Facts: a practical tool to strengthen respiratory advocacy in Europe
Respiratory diseases remain a leading health burden across Europe, yet national strategies are often fragmented or absent. The International Respiratory Coalition's Lung Facts platform offers a comprehensive, up-to-date resource for epidemiological and economic data for major respiratory conditions across 53 European countries. This viewpoint outlines the platform's development and the types of data available, including disease burden, societal costs and risk factor attribution. It also demonstrates how national coalitions are using it to advocate for respiratory health policies. By providing accessible, country-specific information in visual formats, Lung Facts supports benchmarking, evidence-based advocacy and planning of national respiratory strategies. The platform is a dynamic tool intended to strengthen respiratory health policy and empower stakeholders to act on the growing burden of lung disease.
- Open Access
- 10 July 2025
- Published by Wiley in Experimental Physiology
- Vol. 111 (6) , 3010-3025
The modified Borg cycle strength test (mBCST): Feasibility and physiological response in people with COPD and healthy older adults
Accurate prescription of supramaximal exercise requires exercise tests covering the intensity domain between maximal aerobic and peak power output. All‐out tests are commonly used for this objective but are considered challenging for people with chronic obstructive pulmonary disease (COPD) due to the extreme physiological demand. The modified Borg cycle strength test (mBCST), previously used in older adults to achieve supramaximal intensities, might be a suitable alternative in people with COPD. We aimed to determine the feasibility of the mBCST in people with COPD and to compare the physiological response with that of healthy older adults. Eighteen people with COPD and 16 age‐, sex‐ and physical activity‐matched healthy adults performed a cardiopulmonary exercise test and a mBCST. The mBCST is an incremental test [30 s:30 s cycling:rest; with individualized starting load and step size (15–50 W)] with end‐of‐test criteria of a rating of perceived exertion of ≥17 or cadence of 5 s. Feasibility was assessed using a framework covering the aim, interpretability, familiarity, duration, scoring/completion complexity, costs and safety. Measurements of external exercise intensity, rating of perceived exertion, symptoms and cardiorespiratory demand were obtained. The mBCST was deemed feasible according to the feasibility framework. Expressed relative to the cardiopulmonary exercise test, the participants reached supramaximal external exercise intensities during the mBCST [COPD, 145 (125–168)%; healthy, 154 (148–163)%], without differences in intensity or physiological response between groups ( p > 0.05). The mBCST is feasible in people with COPD and enables supramaximal external exercise intensities, with similar physiological response to healthy older adults. The mBCST could be considered when selecting an exercise test to prescribe supramaximal exercise.
- 10 July 2025
- Published by Wiley in Experimental Physiology
- Vol. 111 (6) , 3010-3025
Open AccessThe modified Borg cycle strength test (mBCST): Feasibility and physiological response in people with COPD and healthy older adults
Accurate prescription of supramaximal exercise requires exercise tests covering the intensity domain between maximal aerobic and peak power output. All‐out tests are commonly used for this objective but are considered challenging for people with chronic obstructive pulmonary disease (COPD) due to the extreme physiological demand. The modified Borg cycle strength test (mBCST), previously used in older adults to achieve supramaximal intensities, might be a suitable alternative in people with COPD. We aimed to determine the feasibility of the mBCST in people with COPD and to compare the physiological response with that of healthy older adults. Eighteen people with COPD and 16 age‐, sex‐ and physical activity‐matched healthy adults performed a cardiopulmonary exercise test and a mBCST. The mBCST is an incremental test [30 s:30 s cycling:rest; with individualized starting load and step size (15–50 W)] with end‐of‐test criteria of a rating of perceived exertion of ≥17 or cadence of 5 s. Feasibility was assessed using a framework covering the aim, interpretability, familiarity, duration, scoring/completion complexity, costs and safety. Measurements of external exercise intensity, rating of perceived exertion, symptoms and cardiorespiratory demand were obtained. The mBCST was deemed feasible according to the feasibility framework. Expressed relative to the cardiopulmonary exercise test, the participants reached supramaximal external exercise intensities during the mBCST [COPD, 145 (125–168)%; healthy, 154 (148–163)%], without differences in intensity or physiological response between groups ( p > 0.05). The mBCST is feasible in people with COPD and enables supramaximal external exercise intensities, with similar physiological response to healthy older adults. The mBCST could be considered when selecting an exercise test to prescribe supramaximal exercise.
- Open Access
- 10 April 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (5)
Feasibility and acute physiological responses to supramaximal high-intensity interval training in COPD: a randomised crossover trial
Background: Extrapulmonary manifestations, including cognitive impairment and reduced muscle and cardiovascular function is common in COPD. While high-intensity exercise offers extrapulmonary benefits, its implementation in COPD is challenging. This randomised crossover trial examined the feasibility and physiological responses of a novel supramaximal high-intensity interval-training (SupraHIIT) protocol compared with moderate-intensity continuous training (MICT) in people with COPD and matched healthy controls (HCs). Methods: 16 people with COPD and 16 HCs performed SupraHIIT and MICT. SupraHIIT consisted of ten 6-s intervals at ≈150% and ≈200% of maximum aerobic power (MAP), while MICT was performed for 20 min at 60% of MAP. Outcomes were exercise intensity, change in exerkines, feasibility and cardiorespiratory demand of the modalities. Results: SupraHIIT was feasible and enabled up to a 3.5-fold increase in external exercise intensity compared with MICT (184±66 and 245±88 versus 71±22 W in COPD; p<0.001). All participants could complete SupraHIIT, which was the preferred modality in both groups (p<0.01), whereas 5 of 16 participants with COPD interrupted MICT due to intolerable dyspnoea or exhaustion (p=0.005). Both modalities increased plasma brain-derived neurotrophic factor (pBDNF) by an average of 59% (range 30–87%; p<0.05). When normalised for duration at target power, SupraHIIT produced a 5–10-fold greater increase than MICT. Both modalities lead to a variable response in other exerkines including clusterin, lactate, hepatocyte growth factor and interleukin-6. Conclusion: In COPD, short-duration SupraHIIT is more feasible and enables markedly higher external exercise intensities than MICT. By elevating pBDNF and other potentially beneficial exerkines, it shows potential for extrapulmonary benefits.
- 10 April 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (5)
Open AccessFeasibility and acute physiological responses to supramaximal high-intensity interval training in COPD: a randomised crossover trial
Background: Extrapulmonary manifestations, including cognitive impairment and reduced muscle and cardiovascular function is common in COPD. While high-intensity exercise offers extrapulmonary benefits, its implementation in COPD is challenging. This randomised crossover trial examined the feasibility and physiological responses of a novel supramaximal high-intensity interval-training (SupraHIIT) protocol compared with moderate-intensity continuous training (MICT) in people with COPD and matched healthy controls (HCs). Methods: 16 people with COPD and 16 HCs performed SupraHIIT and MICT. SupraHIIT consisted of ten 6-s intervals at ≈150% and ≈200% of maximum aerobic power (MAP), while MICT was performed for 20 min at 60% of MAP. Outcomes were exercise intensity, change in exerkines, feasibility and cardiorespiratory demand of the modalities. Results: SupraHIIT was feasible and enabled up to a 3.5-fold increase in external exercise intensity compared with MICT (184±66 and 245±88 versus 71±22 W in COPD; p<0.001). All participants could complete SupraHIIT, which was the preferred modality in both groups (p<0.01), whereas 5 of 16 participants with COPD interrupted MICT due to intolerable dyspnoea or exhaustion (p=0.005). Both modalities increased plasma brain-derived neurotrophic factor (pBDNF) by an average of 59% (range 30–87%; p<0.05). When normalised for duration at target power, SupraHIIT produced a 5–10-fold greater increase than MICT. Both modalities lead to a variable response in other exerkines including clusterin, lactate, hepatocyte growth factor and interleukin-6. Conclusion: In COPD, short-duration SupraHIIT is more feasible and enables markedly higher external exercise intensities than MICT. By elevating pBDNF and other potentially beneficial exerkines, it shows potential for extrapulmonary benefits.
- Open Access
- 13 June 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (5)
Muscle fibre satellite cells are located at a greater distance from capillaries in patients with COPD compared with healthy controls
Background: COPD is a disease characterised by skeletal muscle dysfunction. A spatial relationship exists between satellite cells and muscle fibre capillaries, which has been suggested to be of major importance for satellite cell function. In the present study we compared the spatial relationship between satellite cells and capillaries in patients with COPD and age-matched healthy older adults.Methods: Muscle biopsies were obtained from thevastus lateralisof n=18 patients with COPD (8 female, 10 male; age 66±5 years, mild-to-severe airflow obstruction) and n=18 age-, sex- and body mass index-matched healthy control adults (8 female, 10 male; age 68±5 years). Immunohistochemistry was used to assess type I/II muscle fibre size, distribution, myonuclear content, satellite cell number and fibre capillarisation. In addition, type I/II muscle fibre satellite cell distance to its nearest capillary was assessed.Results: The percentage of type II muscle fibres was significantly greater in patients with COPD (62±10%) compared with controls (50±12%, p<0.05). Muscle fibre capillarisation was significantly lower in patients with COPD compared with controls (p<0.05). While satellite cell content was not different between groups, type I and type II satellite cell distance to its nearest capillary was significantly greater in patients with COPD (type I: 21.3±4.8 µm; type II: 26.7±9.3 µm) compared with controls (type I: 16.1±3.5 µm; type II: 22.7±5.8 µm; p<0.05).Conclusion: Satellite cells are located at a greater distance from their nearest capillary in patients with COPD compared with age-matched controls. This increased distance could play a role in impaired satellite cell function in patients with COPD.
- 13 June 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (5)
Open AccessMuscle fibre satellite cells are located at a greater distance from capillaries in patients with COPD compared with healthy controls
Background: COPD is a disease characterised by skeletal muscle dysfunction. A spatial relationship exists between satellite cells and muscle fibre capillaries, which has been suggested to be of major importance for satellite cell function. In the present study we compared the spatial relationship between satellite cells and capillaries in patients with COPD and age-matched healthy older adults.Methods: Muscle biopsies were obtained from thevastus lateralisof n=18 patients with COPD (8 female, 10 male; age 66±5 years, mild-to-severe airflow obstruction) and n=18 age-, sex- and body mass index-matched healthy control adults (8 female, 10 male; age 68±5 years). Immunohistochemistry was used to assess type I/II muscle fibre size, distribution, myonuclear content, satellite cell number and fibre capillarisation. In addition, type I/II muscle fibre satellite cell distance to its nearest capillary was assessed.Results: The percentage of type II muscle fibres was significantly greater in patients with COPD (62±10%) compared with controls (50±12%, p<0.05). Muscle fibre capillarisation was significantly lower in patients with COPD compared with controls (p<0.05). While satellite cell content was not different between groups, type I and type II satellite cell distance to its nearest capillary was significantly greater in patients with COPD (type I: 21.3±4.8 µm; type II: 26.7±9.3 µm) compared with controls (type I: 16.1±3.5 µm; type II: 22.7±5.8 µm; p<0.05).Conclusion: Satellite cells are located at a greater distance from their nearest capillary in patients with COPD compared with age-matched controls. This increased distance could play a role in impaired satellite cell function in patients with COPD.
- Open Access
- 8 June 2024
- Published by Springer Nature in Hernia
- Vol. 28 (4) , 1413-1426
Reliability and validity of surface EMG assessments combined with isometric muscle strength testing in patients with abdominal rectus diastasis and asymptomatic controls
Purpose: Patients with abdominal rectus diastasis (ARD) may have muscular functional impairments, but clinics lack appropriate objective assessment tools. The aim was to establish the relative and absolute reliability, and convergent validity, of muscular activity using Surface Electromyography (SEMG) during isometric abdominal muscle strength testing in patients with ARD and controls without ARD. Methods: Twenty-six patients with ARD were matched for age, sex and BMI with controls without ARD. Participants were tested twice during isometric muscular contractions using SEMG located on six abdominal sites. Mean amplitude, fatigue, and recruitment order were analyzed. Relative reliability was evaluated with Intraclass Correlation Coefficients (ICC), while absolute reliability was estimated by calculating the Standard Error of Measurement and Minimal Detectable Change. Convergent validity was addressed in relation to participant characteristics, functional ability, and symptoms. Results: Mean SEMG amplitude for all abdominal wall muscle contractions showed moderate to excellent relative test–retest reliability, with ICC values ranging from 0.46 to 0.97. In contrast, fatigue and recruitment order displayed poor to moderate relative reliability in both groups. Absolute reliability measures were generally high. A moderate to high convergent validity (ARD: rho-value 0.41–0.70; Controls: rho-value 0.41–0.75) was observed for mean amplitude in relation to a functional sit-to-stand test, abdominal circumference, BMI, back pain, and quality-of-life. Conclusions: The results of applying SEMG during isometric abdominal muscle support practicing the method in clinics, although additional development is needed with further standardization and more functional testing. Furthermore, the method demonstrates construct validity in patients with ARD and in age- and sex-matched controls.
- 8 June 2024
- Published by Springer Nature in Hernia
- Vol. 28 (4) , 1413-1426
Open AccessReliability and validity of surface EMG assessments combined with isometric muscle strength testing in patients with abdominal rectus diastasis and asymptomatic controls
Purpose: Patients with abdominal rectus diastasis (ARD) may have muscular functional impairments, but clinics lack appropriate objective assessment tools. The aim was to establish the relative and absolute reliability, and convergent validity, of muscular activity using Surface Electromyography (SEMG) during isometric abdominal muscle strength testing in patients with ARD and controls without ARD. Methods: Twenty-six patients with ARD were matched for age, sex and BMI with controls without ARD. Participants were tested twice during isometric muscular contractions using SEMG located on six abdominal sites. Mean amplitude, fatigue, and recruitment order were analyzed. Relative reliability was evaluated with Intraclass Correlation Coefficients (ICC), while absolute reliability was estimated by calculating the Standard Error of Measurement and Minimal Detectable Change. Convergent validity was addressed in relation to participant characteristics, functional ability, and symptoms. Results: Mean SEMG amplitude for all abdominal wall muscle contractions showed moderate to excellent relative test–retest reliability, with ICC values ranging from 0.46 to 0.97. In contrast, fatigue and recruitment order displayed poor to moderate relative reliability in both groups. Absolute reliability measures were generally high. A moderate to high convergent validity (ARD: rho-value 0.41–0.70; Controls: rho-value 0.41–0.75) was observed for mean amplitude in relation to a functional sit-to-stand test, abdominal circumference, BMI, back pain, and quality-of-life. Conclusions: The results of applying SEMG during isometric abdominal muscle support practicing the method in clinics, although additional development is needed with further standardization and more functional testing. Furthermore, the method demonstrates construct validity in patients with ARD and in age- and sex-matched controls.
- Open Access
- 30 November 2023
- Published by Taylor & Francis in Pulmonology
- Vol. 29 (6) , 518-534
Impact of acute exacerbations of COPD on patients’ health status beyond pulmonary function: A scoping review
This scoping review summarized the evidence regarding the impact of acute exacerbations of COPD (AECOPD) on patients' health status beyond pulmonary function. PubMed, Embase, and Web of Science were searched. Prospective cohort studies assessing the health status of patients with COPD in a stable phase of the disease and after a follow-up period (where at least one AECOPD occurred) were included. An integrated assessment framework of health status (i.e., physiological functioning, complaints, functional impairment, quality of life) was used. Twenty-two studies were included. AECOPD acutely affected exercise tolerance, quadriceps muscle strength, physical activity levels, symptoms of dyspnoea and fatigue, and impact of the disease. Long-term effects on quadriceps muscle strength, symptoms of dyspnoea and depression, and quality of life were found. Repeated exacerbations negatively impacted the fat-free mass, levels of dyspnoea, impact of the disease and quality of life. Conflicting evidence was found regarding the impact of repeated exacerbations on exercise tolerance and physical activity levels. AECOPD have well-established acute and long-term adverse effects on health status beyond pulmonary function; nevertheless, the recovery trajectory and the impact of repeated exacerbations are still poorly studied. Further prospective research is recommended to draw firm conclusions on these aspects.
- 30 November 2023
- Published by Taylor & Francis in Pulmonology
- Vol. 29 (6) , 518-534
Open AccessImpact of acute exacerbations of COPD on patients’ health status beyond pulmonary function: A scoping review
This scoping review summarized the evidence regarding the impact of acute exacerbations of COPD (AECOPD) on patients' health status beyond pulmonary function. PubMed, Embase, and Web of Science were searched. Prospective cohort studies assessing the health status of patients with COPD in a stable phase of the disease and after a follow-up period (where at least one AECOPD occurred) were included. An integrated assessment framework of health status (i.e., physiological functioning, complaints, functional impairment, quality of life) was used. Twenty-two studies were included. AECOPD acutely affected exercise tolerance, quadriceps muscle strength, physical activity levels, symptoms of dyspnoea and fatigue, and impact of the disease. Long-term effects on quadriceps muscle strength, symptoms of dyspnoea and depression, and quality of life were found. Repeated exacerbations negatively impacted the fat-free mass, levels of dyspnoea, impact of the disease and quality of life. Conflicting evidence was found regarding the impact of repeated exacerbations on exercise tolerance and physical activity levels. AECOPD have well-established acute and long-term adverse effects on health status beyond pulmonary function; nevertheless, the recovery trajectory and the impact of repeated exacerbations are still poorly studied. Further prospective research is recommended to draw firm conclusions on these aspects.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA356
The Borg Cycle Strength Test (BCST) for prescribing supramaximal high-intensity interval training (HIIT) in COPD
Background: Prescription of supramaximal HIIT is ideally based on an all-out test. This is, however, not suitable for people with COPD, leading to the use of workloads obtained during a maximal incremental test (CPET), which are less specific for the prescription of supramaximal HIIT. Hence, we evaluated the feasibility of a submaximal anaerobic test, the BCST, that has been used in older adults to prescribe supramaximal HIIT, and the anaerobic cycle capacity of people with COPD vs. matched healthy controls (HC). Methods: Sixteen persons with COPD and HC performed a CPET and a BCST. The BCST is an incremental stepwise test (30s cycling, 30s rest) with two end-of-test criteria: 1) Rating of perceived exertion (RPE) ≥17 or 2) cadence 5s. End-of-test RPE, symptoms, peak workload (Wpeak) and cardiorespiratory demand were obtained to assess feasibility. Results: A higher Wpeak and lower RPE, symptoms and cardiorespiratory demand were observed in the BCST vs. CPET in both groups (Table1). Absolute BCST Wpeak was significantly lower, while relative BCST Wpeak (%Wpeak CPET) was similar in people with COPD (146±24%) vs. HC (157±17%)(P=0.114). Conclusion: In people with COPD, the BCST is a feasible short-duration submaximal anaerobic test specific for prescribing supramaximal HIIT. Compared to the CPET, it allows for higher workloads with lower cardiorespiratory demand and symptom burden.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA356
The Borg Cycle Strength Test (BCST) for prescribing supramaximal high-intensity interval training (HIIT) in COPD
Background: Prescription of supramaximal HIIT is ideally based on an all-out test. This is, however, not suitable for people with COPD, leading to the use of workloads obtained during a maximal incremental test (CPET), which are less specific for the prescription of supramaximal HIIT. Hence, we evaluated the feasibility of a submaximal anaerobic test, the BCST, that has been used in older adults to prescribe supramaximal HIIT, and the anaerobic cycle capacity of people with COPD vs. matched healthy controls (HC). Methods: Sixteen persons with COPD and HC performed a CPET and a BCST. The BCST is an incremental stepwise test (30s cycling, 30s rest) with two end-of-test criteria: 1) Rating of perceived exertion (RPE) ≥17 or 2) cadence 5s. End-of-test RPE, symptoms, peak workload (Wpeak) and cardiorespiratory demand were obtained to assess feasibility. Results: A higher Wpeak and lower RPE, symptoms and cardiorespiratory demand were observed in the BCST vs. CPET in both groups (Table1). Absolute BCST Wpeak was significantly lower, while relative BCST Wpeak (%Wpeak CPET) was similar in people with COPD (146±24%) vs. HC (157±17%)(P=0.114). Conclusion: In people with COPD, the BCST is a feasible short-duration submaximal anaerobic test specific for prescribing supramaximal HIIT. Compared to the CPET, it allows for higher workloads with lower cardiorespiratory demand and symptom burden.
- Open Access
- 27 July 2023
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 9 (4)
Reference equations for quadriceps strength, endurance and power: a multicentre study
Introduction: The lack of reference values of lower-limb muscle function hinders the clinical recommendations of its measurement in patients with COPD. Therefore, this study aimed to develop reference equations to predict reference values for quadriceps strength, endurance and power and evaluate their construct validity in patients with COPD.Methods: Quadriceps strength, endurance and power were assessed in 158 healthy individuals and 87 patients with COPD. In addition, patients with COPD performed a 6-min walk test (6MWT) and a 1-min sit-to-stand test (1STS). Multiple linear regressions were performed to develop reference equations. The proportion of patients with COPD with reduced quadriceps function was determined, and correlations between quadriceps strength, endurance and power expressed in percentage of predicted values and 6MWT and 1STS performance were used to document the construct validity of the reference equation.Results: Except for quadriceps isometric endurance, the proposed reference equations explained 50–70% of the variance of the quadriceps properties in healthy individuals. All quadriceps properties were systematically reduced in a large proportion of patients with COPD compared to healthy individuals. Correlation coefficients between quadriceps properties expressed in percentage of predicted values and 6MWT and 1STS performance ranged between 0.28 and 0.49 (all p<0.05).Conclusion: In healthy individuals, age, sex, height and body mass index explained 50–70% of the variance of quadriceps strength, endurance and power. When expressed in percentage of predicted values, these quadriceps properties correlated with 6MWT and 1STS performance, suggesting construct validity of the reference values in patients with COPD.
- 27 July 2023
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 9 (4)
Open AccessReference equations for quadriceps strength, endurance and power: a multicentre study
Introduction: The lack of reference values of lower-limb muscle function hinders the clinical recommendations of its measurement in patients with COPD. Therefore, this study aimed to develop reference equations to predict reference values for quadriceps strength, endurance and power and evaluate their construct validity in patients with COPD.Methods: Quadriceps strength, endurance and power were assessed in 158 healthy individuals and 87 patients with COPD. In addition, patients with COPD performed a 6-min walk test (6MWT) and a 1-min sit-to-stand test (1STS). Multiple linear regressions were performed to develop reference equations. The proportion of patients with COPD with reduced quadriceps function was determined, and correlations between quadriceps strength, endurance and power expressed in percentage of predicted values and 6MWT and 1STS performance were used to document the construct validity of the reference equation.Results: Except for quadriceps isometric endurance, the proposed reference equations explained 50–70% of the variance of the quadriceps properties in healthy individuals. All quadriceps properties were systematically reduced in a large proportion of patients with COPD compared to healthy individuals. Correlation coefficients between quadriceps properties expressed in percentage of predicted values and 6MWT and 1STS performance ranged between 0.28 and 0.49 (all p<0.05).Conclusion: In healthy individuals, age, sex, height and body mass index explained 50–70% of the variance of quadriceps strength, endurance and power. When expressed in percentage of predicted values, these quadriceps properties correlated with 6MWT and 1STS performance, suggesting construct validity of the reference values in patients with COPD.
- 24 July 2023
- Published by Wiley in Acta Physiologica
- Vol. 239 (1) , e14020
Extensive profiling of histidine‐containing dipeptides reveals species‐ and tissue‐specific distribution and metabolism in mice, rats, and humans
Aim: Histidine‐containing dipeptides (HCDs) are pleiotropic homeostatic molecules with potent antioxidative and carbonyl quenching properties linked to various inflammatory, metabolic, and neurological diseases, as well as exercise performance. However, the distribution and metabolism of HCDs across tissues and species are still unclear.Methods: Using a sensitive UHPLC–MS/MS approach and an optimized quantification method, we performed a systematic and extensive profiling of HCDs in the mouse, rat, and human body (inn = 26,n = 25, andn = 19 tissues, respectively).Results: Our data show that tissue HCD levels are uniquely produced by carnosine synthase (CARNS1), an enzyme that was preferentially expressed by fast‐twitch skeletal muscle fibres and brain oligodendrocytes. Cardiac HCD levels are remarkably low compared to other excitable tissues. Carnosine is unstable in human plasma, but is preferentially transported within red blood cells in humans but not rodents. The low abundant carnosine analogue N‐acetylcarnosine is the most stable plasma HCD, and is enriched in human skeletal muscles. Here, N‐acetylcarnosine is continuously secreted into the circulation, which is further induced by acute exercise in a myokine‐like fashion.Conclusion: Collectively, we provide a novel basis to unravel tissue‐specific, paracrine, and endocrine roles of HCDs in human health and disease.
- 24 July 2023
- Published by Wiley in Acta Physiologica
- Vol. 239 (1) , e14020
Extensive profiling of histidine‐containing dipeptides reveals species‐ and tissue‐specific distribution and metabolism in mice, rats, and humans
Aim: Histidine‐containing dipeptides (HCDs) are pleiotropic homeostatic molecules with potent antioxidative and carbonyl quenching properties linked to various inflammatory, metabolic, and neurological diseases, as well as exercise performance. However, the distribution and metabolism of HCDs across tissues and species are still unclear.Methods: Using a sensitive UHPLC–MS/MS approach and an optimized quantification method, we performed a systematic and extensive profiling of HCDs in the mouse, rat, and human body (inn = 26,n = 25, andn = 19 tissues, respectively).Results: Our data show that tissue HCD levels are uniquely produced by carnosine synthase (CARNS1), an enzyme that was preferentially expressed by fast‐twitch skeletal muscle fibres and brain oligodendrocytes. Cardiac HCD levels are remarkably low compared to other excitable tissues. Carnosine is unstable in human plasma, but is preferentially transported within red blood cells in humans but not rodents. The low abundant carnosine analogue N‐acetylcarnosine is the most stable plasma HCD, and is enriched in human skeletal muscles. Here, N‐acetylcarnosine is continuously secreted into the circulation, which is further induced by acute exercise in a myokine‐like fashion.Conclusion: Collectively, we provide a novel basis to unravel tissue‐specific, paracrine, and endocrine roles of HCDs in human health and disease.
- Open Access
- 9 February 2023
- Published by Frontiers Media SA in Frontiers in Rehabilitation Sciences
- Vol. 4, 1130757
Editorial: Women in science: Pulmonary rehabilitation
Editorial: Women in science: Pulmonary rehabilitation
- 9 February 2023
- Published by Frontiers Media SA in Frontiers in Rehabilitation Sciences
- Vol. 4, 1130757
Open AccessEditorial: Women in science: Pulmonary rehabilitation
Editorial: Women in science: Pulmonary rehabilitation